A detailed history of Folketrygdfondet transactions in Novo Nordisk A S stock. As of the latest transaction made, Folketrygdfondet holds 8,863,625 shares of NVO stock, worth $963 Million. This represents 24.54% of its overall portfolio holdings.

Number of Shares
8,863,625
Previous 8,838,723 0.28%
Holding current value
$963 Million
Previous $1.26 Billion 16.35%
% of portfolio
24.54%
Previous 25.33%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $2.97 Million - $3.62 Million
24,902 Added 0.28%
8,863,625 $1.06 Billion
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $10.1 Million - $12.1 Million
82,689 Added 0.94%
8,838,723 $1.26 Billion
Q1 2024

Apr 15, 2024

BUY
$102.11 - $135.92 $12.7 Million - $17 Million
124,770 Added 1.45%
8,756,034 $1.12 Billion
Q4 2023

Feb 08, 2024

BUY
$87.78 - $105.45 $19.8 Million - $23.8 Million
225,822 Added 2.69%
8,631,264 $893 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $371 Million - $813 Million
4,074,407 Added 94.07%
8,405,442 $764 Million
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $12.6 Million - $14 Million
81,045 Added 1.91%
4,331,035 $701 Million
Q1 2023

Apr 20, 2023

SELL
$132.34 - $159.14 $4.61 Million - $5.55 Million
-34,868 Reduced 0.81%
4,249,990 $676 Million
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $2.28 Million - $3 Million
22,199 Added 0.52%
4,284,858 $580 Million
Q3 2022

Oct 28, 2022

BUY
$95.28 - $116.93 $11.4 Million - $14 Million
119,781 Added 2.89%
4,262,659 $425 Million
Q2 2022

Aug 08, 2022

BUY
$103.24 - $121.81 $379 Million - $447 Million
3,666,475 Added 769.62%
4,142,878 $462 Million
Q1 2022

May 06, 2022

SELL
$93.1 - $112.54 $367 Million - $444 Million
-3,943,480 Reduced 89.22%
476,403 $52.9 Million
Q4 2021

Feb 01, 2022

SELL
$95.88 - $117.08 $28.3 Million - $34.6 Million
-295,634 Reduced 6.27%
4,419,883 $495 Million
Q2 2021

Aug 04, 2021

BUY
$67.66 - $84.76 $31.5 Million - $39.5 Million
466,107 Added 10.97%
4,715,517 $395 Million
Q1 2021

May 04, 2021

SELL
$67.06 - $75.82 $94.9 Million - $107 Million
-1,414,792 Reduced 24.98%
4,249,410 $286 Million
Q4 2020

Jan 29, 2021

BUY
$63.89 - $73.8 $9 Million - $10.4 Million
140,792 Added 2.55%
5,664,202 $396 Million
Q2 2020

Aug 07, 2020

SELL
$58.54 - $67.94 $13.1 Million - $15.2 Million
-223,012 Reduced 3.88%
5,523,410 $362 Million
Q1 2020

May 13, 2020

BUY
$49.46 - $64.78 $101,096 - $132,410
2,044 Added 0.04%
5,746,422 $346 Million
Q3 2019

Nov 12, 2019

BUY
$47.54 - $53.43 $23.8 Million - $26.7 Million
500,000 Added 9.53%
5,744,378 $297 Million
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $384,286 - $430,936
-8,213 Reduced 0.16%
5,244,378 $268 Million
Q1 2019

May 09, 2019

SELL
$46.36 - $52.63 $22.3 Million - $25.3 Million
-480,000 Reduced 8.37%
5,252,591 $275 Million
Q4 2018

Feb 13, 2019

BUY
$41.54 - $47.25 $1.61 Million - $1.83 Million
38,642 Added 0.68%
5,732,591 $264 Million
Q1 2018

Apr 30, 2018

SELL
$48.49 - $58.14 $57.1 Million - $68.5 Million
-1,178,094 Reduced 17.14%
5,693,949 $280 Million
Q4 2017

Feb 13, 2018

SELL
$47.53 - $53.73 $16.4 Million - $18.5 Million
-345,000 Reduced 4.78%
6,872,043 $369 Million
Q3 2017

Nov 09, 2017

BUY
$41.15 - $49.22 $12.5 Million - $14.9 Million
302,851 Added 4.38%
7,217,043 $348 Million
Q2 2017

Aug 09, 2017

BUY
N/A
6,914,192
6,914,192 $297 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $245B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Folketrygdfondet Portfolio

Follow Folketrygdfondet and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Folketrygdfondet, based on Form 13F filings with the SEC.

News

Stay updated on Folketrygdfondet with notifications on news.